Shalby balance sheet

As of Mar 2026

Total assets: ₹1,839cr+8.0% on Mar 2025
Shareholders' equity: ₹1,006cr+1.0% on Mar 2025
Total debt: ₹540cr+26.5% on Mar 2025
Cash and investments: ₹84.2cr−35.0% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	922	848	840	668
	0.4	8.0	15.4	6.2
	56.9	56.9	56.9	10.2
	66.7	50.4	69.8	7.0
	18.4	13.9	—	4.4
	12.4	22.4	35.6	10.7
	12.4	22.4	35.6	10.7
	0.0	6.7	—	0.0
	42.7	39.2	38.1	31.0
	1,120	1,046	1,055	737
	376	319	235	185
	62.3	94.6	80.6	146
	228	175	145	106
	21.9	34.8	27.2	12.2
	0.0	0.1	0.0	0.0
	0.0	0.0	10.6	0.0
	9.6	10.9	54.0	57.5
	322	316	317	322
	20.7	23.1	—	10.0
	719	658	552	544
	1,839	1,704	1,608	1,281
Equity
	108	107	107	107
	898	885	893	820
	1,005	992	1,000	928
	0.5	3.1	7.4	−0.1
	1,006	995	1,008	928
Liabilities
	153	137	176	102
	41.9	0.3	51.3	0.4
	195	137	227	102
	7.6	6.0	4.2	2.6
	48.6	63.1	35.0	43.4
	6.8	46.8	10.0	3.1
	258	253	276	159
	387	290	138	78.9
	128	118	130	87.9
	41.1	18.7	37.1	12.4
	556	427	305	179
	4.4	3.6	3.2	1.5
	15.0	24.6	15.4	12.7
	576	455	323	194
	833	708	600	354
	1,839	1,704	1,608	1,281
Assets — additional as-filed lines
	—	—	—	26.7
Liabilities — additional as-filed lines
	—	0.0	0.0	0.9
	—	0.0	0.0	8.3
Trade payables — MSME split
	5.2	4.0	—	—
	123	114	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHALBY₹121.96

Shalby Limited

· Pharma & Health

₹ CrorePeersGKSL GPTHEALTH INDRAMEDCO ARTEMISMED LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹1,311 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	668.0	839.6	848.2	922.3	922.3
+ Capital Work-in-Progress	6.2	15.4	8.0	0.4	0.4
+ Goodwill	10.2	56.9	56.9	56.9	56.9
+ Other Intangibles	7.0	69.8	50.4	66.7	66.7
+ Intangibles under Development	4.4	—	13.9	18.4	18.4
+ Other Non-current Financial Assets	10.7	35.6	22.4	12.4	12.4
Non-current Financial Assets	10.7	35.6	22.4	12.4	12.4
+ Deferred Tax Assets	0.0	—	6.7	0.0	0.0
+ Other Non-current Assets	31.0	38.1	39.2	42.7	42.7
Total Non-current Assets	737.4	1,055.3	1,045.7	1,119.8	1,119.8
Current Assets
+ Inventories	185.4	235.2	319.2	376.4	376.4
+ Current Investments	145.7	80.6	94.6	62.3	62.3
+ Trade Receivables	106.4	144.6	175.2	228.4	228.4
+ Cash & Cash Equivalents	12.2	27.2	34.8	21.9	21.9
+ Other Bank Balances	0.0	0.0	0.1	0.0	0.0
+ Short-term Loans	0.0	10.6	0.0	0.0	0.0
+ Other Current Financial Assets	57.5	54.0	10.9	9.6	9.6
Current Financial Assets	321.9	317.0	315.6	322.2	322.2
+ Other Current Assets	10.0	—	23.1	20.7	20.7
Total Current Assets	544.0	552.3	658.0	719.3	719.3
Total Assets	1,281.4	1,607.5	1,703.7	1,839.1	1,839.1
Equity
+ Equity Share Capital	107.3	107.4	107.5	107.5	107.5
+ Other Equity / Reserves	820.4	893.0	884.7	897.7	897.7
Equity — Owners of Parent	927.7	1,000.4	992.2	1,005.2	1,005.2
+ Minority Interest	-0.1	7.4	3.1	0.5	0.5
Total Equity	927.6	1,007.8	995.3	1,005.7	1,005.7
Liabilities
+ Borrowings — Non-current	101.6	176.0	136.7	152.9	152.9
+ Other Non-current Financial Liab	0.4	51.3	0.3	41.9	41.9
Non-current Financial Liabilities	101.9	227.3	137.0	194.7	194.7
+ Provisions — Non-current	2.6	4.2	6.0	7.6	7.6
+ Deferred Tax Liabilities	43.4	35.0	63.1	48.6	48.6
+ Other Non-current Liabilities	3.1	10.0	46.8	6.8	6.8
Non-current Liabilities	159.4	276.5	253.0	257.7	257.7
+ Borrowings — Current	78.9	138.0	290.0	386.7	386.7
+ Trade Payables	87.9	129.6	118.4	128.5	128.5
+ Other Current Financial Liab	12.4	37.1	18.7	41.1	41.1
Current Financial Liabilities	179.3	304.6	427.2	556.3	556.3
+ Provisions — Current	1.5	3.2	3.6	4.4	4.4
+ Other Current Liabilities	12.7	15.4	24.6	15.0	15.0
Current Liabilities	194.4	323.3	455.3	575.7	575.7
Total Liabilities	353.7	599.7	708.3	833.4	833.4
Total Equity & Liabilities	1,281.4	1,607.5	1,703.7	1,839.1	1,839.1
Assets — additional as-filed lines
+ Current Tax Assets	26.7	—	—	—	—
Liabilities — additional as-filed lines
+ Deferred Government Grants — Current	0.9	0.0	0.0	—	—
+ Deferred Government Grants — Non-current	8.3	0.0	0.0	—	—
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	4.0	5.2	5.2
+ Dues to Other Creditors — Current	—	—	114.5	123.3	123.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.